HomeCompareGKTRF vs MRK

GKTRF vs MRK: Dividend Comparison 2026

GKTRF yields 1.82% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GKTRF wins by $42.76M in total portfolio value· pulled ahead in Year 3
10 years
GKTRF
GKTRF
● Live price
1.82%
Share price
$26.50
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.82M
Annual income
$38,729,103.11
Full GKTRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GKTRF vs MRK

📍 GKTRF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGKTRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GKTRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GKTRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GKTRF
Annual income on $10K today (after 15% tax)
$154.55/yr
After 10yr DRIP, annual income (after tax)
$32,919,737.64/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GKTRF beats the other by $32,911,409.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GKTRF + MRK for your $10,000?

GKTRF: 50%MRK: 50%
100% MRK50/50100% GKTRF
Portfolio after 10yr
$21.44M
Annual income
$19,369,450.62/yr
Blended yield
90.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GKTRF
No analyst data
Altman Z
0.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GKTRF buys
0
MRK buys
0
No recent congressional trades found for GKTRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGKTRFMRK
Forward yield1.82%2.76%
Annual dividend / share$0.48$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$42.82M$56.8K
Annual income after 10y$38,729,103.11$9,798.13
Total dividends collected$42.48M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GKTRF vs MRK ($10,000, DRIP)

YearGKTRF PortfolioGKTRF Income/yrMRK PortfolioMRK Income/yrGap
1$11,064$363.65$11,206$366.19$142.00MRK
2$12,590$752.01$12,650$502.35$60.00MRK
3← crossover$15,071$1,599.56$14,407$694.19+$664.00GKTRF
4$19,705$3,578.97$16,585$967.82+$3.1KGKTRF
5$29,831$8,746.56$19,342$1,363.89+$10.5KGKTRF
6$56,669$24,749.94$22,913$1,947.19+$33.8KGKTRF
7$148,518$87,882.04$27,662$2,823.89+$120.9KGKTRF
8$589,421$430,506.71$34,159$4,173.35+$555.3KGKTRF
9$3,824,226$3,193,545.54$43,337$6,308.80+$3.78MGKTRF
10$42,821,025$38,729,103.11$56,776$9,798.13+$42.76MGKTRF

GKTRF vs MRK: Complete Analysis 2026

GKTRFStock

GEK TERNA Holdings, Real Estate, Construction S.A., together with its subsidiaries, engages in the construction, real estate, mining, electricity, and concession businesses in Greece, the Balkans, the Middle East, Eastern Europe, the United States, and internationally. The company is involved in the construction of motorways, rail networks, buildings, hospitals, museums, industrial facilities, hydroelectric projects, dams, power plants, etc. for public and private sectors; and the financing, management, and commercial operation of concession projects, such as motorways and parking stations. It also develops and operates wind farms, hydroelectric projects, waste treatment and biogas production plants, and photovoltaic parks, as well as develops pumped storage and infrastructure projects. In addition, the company produces 895.3 MW of electric energy and trades in natural gas. Further, it engages in the acquisition, development, and exploitation of real estate properties, including business centers, industrial parks, entertainment parks, residential properties, hotels, etc.; production of quarry products; and exploitation of magnesite quarries. Additionally, the company operates thermal power plants with a total installed capacity of 147 MW and 435 MW in Viotia, Greece. GEK TERNA Holdings, Real Estate, Construction S.A. was formerly known as Ermis Real Estate Constructions Enterprises S.A. The company was founded in 1960 and is headquartered in Athens, Greece.

Full GKTRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GKTRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GKTRF vs SCHDGKTRF vs JEPIGKTRF vs OGKTRF vs KOGKTRF vs MAINGKTRF vs JNJGKTRF vs ABBVGKTRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.